The Growth of Controlled Medication Flexibilities by Agencies Make Telehealth Prescribing Simpler
The DEA and SAMHSA have extended telehealth prescribing flexibilities for controlled substances through November 11, 2024, following a temporary rule. The move comes after several healthcare organizations, including the AHA, requested continued telehealth prescribing…
Continue Reading
